デュシェンヌ型筋ジストロフィーの疫学的予測...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 9

2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
2.3 Upcoming Related Reports 11

3 Epidemiology 12
3.1 Disease Background 12
3.2 Risk Factors and Comorbidities 13
3.3 Global Trends 14
3.4 Forecast Methodology 16
3.4.1 Sources Used 21
3.4.2 Sources Not Used 23
3.4.3 Forecast Assumptions and Methods 24
3.5 Epidemiological Forecast for DMD (2013-2023) 29
3.5.1 Diagnosed Prevalent Cases of DMD (All Ages) 29
3.5.2 Diagnosed Prevalent Cases of DMD (Ages 5-13 Years) 31
3.5.3 Age-Specific Diagnosed Prevalent Cases of DMD (All Ages) 32
3.5.4 Age-Standardized Diagnosed Prevalence of DMD 34
3.6 Epidemiological Forecast for Nonsense Mutations in DMD (2013-2023) 35
3.7 Epidemiological Forecast for the Applicability of Exon Skipping Therapies in DMD (2013-2023) 37
3.7.1 Diagnosed Prevalent Cases of DMD Eligible for an Exon 51 Skipping Therapy (All Ages) 37
3.7.2 Diagnosed Prevalent Cases of DMD Eligible for an Exon 45 Skipping Therapy (All Ages) 38
3.7.3 Diagnosed Prevalent Cases of DMD Eligible for an Exon 53 Skipping Therapy (All Ages) 40
3.7.4 Diagnosed Prevalent Cases of DMD Eligible for an Exon 44 Skipping Therapy (All Ages) 41
3.8 Epidemiological Forecast for BMD (2013-2023) 43
3.8.1 Diagnosed Prevalent Cases of BMD (All Ages) 43
3.8.2 Age-Specific Diagnosed Prevalent Cases of BMD (All Ages) 44
3.8.3 Age-Standardized Diagnosed Prevalence of BMD 46
3.9 Discussion 47
3.9.1 Epidemiological Forecast Insight 47
3.9.2 Limitations of the Analysis 48
3.9.3 Strengths of the Analysis 49

4 Appendix 50
4.1 Bibliography 50
4.2 About the Authors 53
4.2.1 Epidemiologists 53
4.2.2 Reviewers 53
4.2.3 Global Director of Therapy Analysis and Epidemiology 54
4.2.4 Global Head of Healthcare 55
4.3 About GlobalData 56
4.4 About EpiCast 56
4.5 Disclaimer 57